You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 19, 2024

DESFLURANE Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Desflurane, and when can generic versions of Desflurane launch?

Desflurane is a drug marketed by Shanghai Hengrui and is included in one NDA.

The generic ingredient in DESFLURANE is desflurane. There are three drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the desflurane profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Desflurane

A generic version of DESFLURANE was approved as desflurane by SHANGHAI HENGRUI on February 26th, 2018.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for DESFLURANE?
  • What are the global sales for DESFLURANE?
  • What is Average Wholesale Price for DESFLURANE?
Drug patent expirations by year for DESFLURANE
Recent Clinical Trials for DESFLURANE

Identify potential brand extensions & 505(b)(2) entrants

Ajou University School of MedicineN/A
Jason ChuiPhase 4
King Saud Medical CityPhase 3

See all DESFLURANE clinical trials

Pharmacology for DESFLURANE
Drug ClassGeneral Anesthetic
Physiological EffectGeneral Anesthesia
Anatomical Therapeutic Chemical (ATC) Classes for DESFLURANE
Paragraph IV (Patent) Challenges for DESFLURANE
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SUPRANE Inhalation desflurane 99.9% 020118 1 2008-09-11

US Patents and Regulatory Information for DESFLURANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Shanghai Hengrui DESFLURANE desflurane LIQUID;INHALATION 208234-001 Feb 26, 2018 AN RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.